Publication & Citation Trends
Publications
87 total
EE36 Impact of Home Hospitalization on the Cost of Care for 1ST Line Treatment of Locally Advanced or Metastatic HER2+ Breast Cancer OA
Cited by 0
Semantic Scholar
The cost-effectiveness of atidarsagene autotemcel for the treatment of metachromatic leukodystrophy in France
Cited by 0
Semantic Scholar
EE284 Cost-Effectiveness of Pembrolizumab in Combination With Chemotherapy As First-Line Treatment of Advanced or Metastatic Esophageal Cancer or HER2-Negative Gastroesophageal Junction Adenocarcinoma in France
Cited by 0
Semantic Scholar
EE10 Cost-Effectiveness of Pembrolizumab Plus Chemotherapies for First-Line Treatment in Locally Advanced Unresectable or Metastatic Triple Negative Breast Cancer (MTNBC) in France
Cited by 0
Semantic Scholar
EE24 The Cost-Effectiveness of Atidarsagene Autotemcel for the Treatment of Metachromatic Leukodystrophy (MLD) in France OA
Cited by 0
Semantic Scholar
EE355 Budget Impact Model of a New rFVIIa (Eptacog Beta), for the On-Demand Treatment of Spontaneous Bleeding Events and Surgical Bleedings Among Hemophilia Patients with Inhibitors: A Payer Perspective From UK OA
Cited by 0
Semantic Scholar
PCN277 Analysis of Treatment Sequences in HER2-Positive EARLY Breast Cancer Patients: A Retrospective Study from the French National Hospital Database Using a Machine Learning Algorithm, the TAK OA
Cited by 0
Semantic Scholar
PMU74 Approximation of Time to Off Treatment Curves in Medico-Economic MODEL OA
Cited by 0
Semantic Scholar
Research Topics
Health Systems, Economic Evaluations, Quality of Life
(23)
Economic and Financial Impacts of Cancer
(16)
Cancer Risks and Factors
(13)
Pharmaceutical Economics and Policy
(12)
Lung Cancer Treatments and Mutations
(8)
Affiliations
Roche (Switzerland)
Inserm
GlaxoSmithKline (United Kingdom)
Ibero American University
Université Paris-Saclay